{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:55:48Z","timestamp":1759334148257,"version":"build-2065373602"},"reference-count":53,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Vitiligo is a chronic, progressive skin disorder characterized by the development of sharply demarcated depigmented patches due to the loss of melanocytes. Alopecia areata (AA) is an autoimmune condition that presents with sudden, non-scarring hair loss affecting the scalp or other body areas. Objective: To evaluate serum granulysin (GNLY) levels in patients with vitiligo and AA to explore its potential role in the pathogenesis and activity of both diseases. Methods: A total of 80 participants were included: 65 patients and 15 healthy controls. Patients were divided into four groups: active vitiligo (n = 25), stable vitiligo (n = 25), active AA (n = 15), and a control group (n = 15). Serum GNLY levels were measured and analyzed in relation to clinical and dermoscopic features. Results: No significant correlation was found between GNLY levels and either age or Vitiligo Area Scoring Index in vitiligo patients. However, serum GNLY levels showed a significant association with the Vitiligo Disease Activity score. GNLY levels did not correlate with sex or the starburst pattern. In contrast, significant associations were found between elevated GNLY levels and dermoscopic signs of activity, including ill-defined lesion borders, satellite lesions, perifollicular pigmentation, and loss of pigment network. Both vitiligo and AA patients exhibited significantly higher GNLY levels than controls, with the highest concentrations observed in the active vitiligo group. Conclusions: The significant rise in serum GNLY levels in vitiligo and AA suggests a pathogenic role, with higher levels in active vitiligo indicating its potential utility as a biomarker for monitoring disease activity.<\/jats:p>","DOI":"10.3390\/jcm14196894","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T09:12:23Z","timestamp":1759223543000},"page":"6894","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6186-848X","authenticated-orcid":false,"given":"Hayam Ali","family":"AlRasheed","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 11564, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira Aboelmakarem","family":"Korkor","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmina Ahmed","family":"El Attar","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowida Raafat","family":"Yousef","sequence":"additional","affiliation":[{"name":"Biochemistry Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-4573","authenticated-orcid":false,"given":"Mostafa M.","family":"Bahaa","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta 34517, Egypt"},{"name":"Pharmay Practice Department, Faculty of Pharmacy, Mansoura National University, Gamasa 7731168, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab Abdel Samad","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e16660","DOI":"10.1111\/jocd.16660","article-title":"A systematic review of Case Series and clinical trials investigating Regenerative Medicine for the Treatment of Vitiligo","volume":"24","author":"Jafarzadeh","year":"2025","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12016-025-09048-z","article-title":"Epigenetic Modifications in Vitiligo","volume":"68","author":"Huang","year":"2025","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2310\/7750.2012.12005","article-title":"The pathogenesis of vitiligo","volume":"17","author":"Malhotra","year":"2013","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/JD9.0000000000000346","article-title":"An extensive review of vitiligo-associated conditions","volume":"7","author":"Premkumar","year":"2024","journal-title":"Int. J. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00403-025-04183-1","article-title":"Enhancing hair regrowth in Alopecia areata: The power duo of CO2 fractional laser and Bimatoprost","volume":"317","author":"Nouh","year":"2025","journal-title":"Arch. Dermatol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e70202","DOI":"10.1111\/jocd.70202","article-title":"Novel Electrotrichogenic Device Promotes Hair Growth in Men with Androgenetic Alopecia: A Pilot Study","volume":"24","author":"Jellard","year":"2025","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e70182","DOI":"10.1002\/mco2.70182","article-title":"Alopecia Areata: Pathogenesis, Diagnosis, and Therapies","volume":"6","author":"Ma","year":"2025","journal-title":"MedComm"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1586\/1744666X.2015.1085306","article-title":"The role of lymphocytes in the development and treatment of alopecia areata","volume":"11","author":"Guo","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yamaguchi, H.L., Yamaguchi, Y., and Peeva, E. (2024). Pathogenesis of alopecia areata and vitiligo: Commonalities and differences. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084409"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Zhang, Y.-X., Xiong, Y.-Y., and Li, Y.-M. (2025). Pathogenesis and regenerative therapy in vitiligo and alopecia areata: Focus on hair follicle. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1510363"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/exd.12264","article-title":"Vitiligo and alopecia areata: Apples and oranges?","volume":"22","author":"Harris","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4103\/idoj.idoj_386_23","article-title":"Serum granulysin as a possible key marker of vitiligo activity and severity","volume":"15","author":"Mustafa","year":"2024","journal-title":"Indian Dermatol. Online J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nm.4023","article-title":"Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites","volume":"22","author":"Dotiwala","year":"2016","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/cimb46040186","article-title":"Precision dermatology: A review of molecular biomarkers and personalized therapies","volume":"46","author":"Tan","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/eji.200323977","article-title":"Granulysin in human serum as a marker of cell-mediated immunity","volume":"33","author":"Ogawa","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bcp.2013.11.004","article-title":"Granulysin induces apoptotic cell death and cleavage of the autophagy regulator Atg5 in human hematological tumors","volume":"87","author":"Aporta","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_17","first-page":"1634","article-title":"Increased granulysin in the peripheral blood and tissues of patients with oral lichen planus","volume":"12","author":"Xu","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bjd.12396","article-title":"T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata","volume":"169","author":"Tembhre","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12476636","article-title":"Cytolytic antibodies to melanocytes in vitiligo","volume":"100","author":"Cui","year":"1993","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00128071-200102030-00006","article-title":"Vitiligo. pathogenesis and treatment","volume":"12","author":"Njoo","year":"2001","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Strzelec, M., Detka, J., Mieszczak, P., Soboci\u0144ska, M.K., and Majka, M. (2023). Immunomodulation\u2014A general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1127704"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.tube.2007.01.003","article-title":"Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy","volume":"87","author":"Buccheri","year":"2007","journal-title":"Tuberculosis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/pcmr.12974","article-title":"Vitiligo: Translational research and effective therapeutic strategies","volume":"34","author":"Thakur","year":"2021","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/ijd.13795","article-title":"Dermoscopy in vitiligo: Diagnosis and beyond","volume":"57","author":"Sonthalia","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/exd.12372","article-title":"Role of oxidative stress and autoimmunity in onset and progression of vitiligo","volume":"23","author":"Laddha","year":"2014","journal-title":"Exp. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdermsci.2013.08.009","article-title":"Serum granulysin as a possible key marker of the activity of alopecia areata","volume":"73","author":"Ono","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/jdv.18134","article-title":"Assessing the dynamic changes in vitiligo: Reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS)","volume":"36","author":"Depaepe","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/pcmr.13069","article-title":"A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment: Dermoscopy and disease activity in vitiligo","volume":"36","author":"Gupta","year":"2023","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1111\/jocd.14922","article-title":"Differentiating active from stable vitiligo: The role of dermoscopic findings and their relation to CXCL10","volume":"21","author":"Ibrahim","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_30","first-page":"e2023197","article-title":"Dermatoscopic patterns in vitiligo","volume":"13","year":"2023","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_31","first-page":"2066","article-title":"Dermoscopy\u2014A tool to assess stability in vitiligo","volume":"4","author":"Purnima","year":"2017","journal-title":"Int. J. Contemp. Med. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.compmedimag.2004.03.001","article-title":"Demonstration of residual perifollicular pigmentation in localized vitiligo--a reverse and novel application of digital epiluminescence dermoscopy","volume":"28","author":"Chuh","year":"2004","journal-title":"Comput. Med. Imaging Graph."},{"key":"ref_33","first-page":"112","article-title":"Dermoscopy: A tool to assess stability in Vitiligo","volume":"175","author":"Chandrashekhar","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_34","first-page":"343","article-title":"Interfering with the IFN-\u03b3\/CXCL10 pathway to develop new targeted treatments for vitiligo","volume":"3","author":"Rashighi","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"ref_35","first-page":"1031","article-title":"The role of chemokine CXC-motif receptor 3 in vitiligo: A clinical and immunohistochemical study","volume":"33","author":"Farag","year":"2020","journal-title":"Menoufia Med. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/jocd.13598","article-title":"Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy","volume":"20","author":"Oba","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_37","first-page":"1036","article-title":"Serum granulysin as a possible key marker of activity of alopecia areata","volume":"33","author":"Maraee","year":"2020","journal-title":"Menoufia Med. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Younes, A.-K., Hammad, R., Othman, M., and Sobhy, A. (2022). CD4, CD8 and natural killer cells are depressed in patients with alopecia areata: Their association with disease activity. BMC Immunol., 23.","DOI":"10.1186\/s12865-022-00486-4"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.15419\/bmrat.v8i10.702","article-title":"Evaluation of serum levels of IL-6, IL-10, and TNF-alpha in alopecia areata patients: A systematic review and meta-analysis","volume":"8","author":"Torkestani","year":"2021","journal-title":"Biomed. Res. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Peterle, L., Sanfilippo, S., Borgia, F., Cicero, N., and Gangemi, S. (2023). Alopecia areata: A review of the role of oxidative stress, possible biomarkers, and potential novel therapeutic approaches. Antioxidants, 12.","DOI":"10.3390\/antiox12010135"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clindermatol.2022.02.009","article-title":"The genetics of pediatric cutaneous autoimmunity: The sister diseases vitiligo and alopecia areata","volume":"40","author":"Silverberg","year":"2022","journal-title":"Clin. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.imlet.2019.11.005","article-title":"Granulysin: The attractive side of a natural born killer","volume":"217","author":"Sparrow","year":"2020","journal-title":"Immunol. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13619-022-00132-9","article-title":"A mouse model of vitiligo based on endogenous auto-reactive CD8+ T cell targeting skin melanocyte","volume":"11","author":"Chen","year":"2022","journal-title":"Cell Regen."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s12016-022-08954-w","article-title":"Hair follicle melanocytes initiate autoimmunity in alopecia areata: A trigger point","volume":"63","author":"Xie","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1038\/s41467-021-26187-x","article-title":"CD127+ CD94+ innate lymphoid cells expressing granulysin and perforin are expanded in patients with Crohn\u2019s disease","volume":"12","author":"Krabbendam","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Thompson, R., and Cao, X. (2024). Reassessing granzyme B: Unveiling perforin-independent versatility in immune responses and therapeutic potentials. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1392535"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1399-0039.2008.01218.x","article-title":"Biology and clinical relevance of granulysin","volume":"73","author":"Krensky","year":"2009","journal-title":"Tissue Antigens"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Drvar, V., \u0106urko-Cofek, B., Karleu\u0161a, L., Aralica, M., Rogoznica, M., Kehler, T., Legovi\u0107, D., Rukavina, D., and Laskarin, G. (2022). Granulysin expression and granulysin-mediated apoptosis in the peripheral blood of osteoarthritis patients. Biomed. Rep., 16.","DOI":"10.3892\/br.2022.1527"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40257-017-0298-5","article-title":"Vitiligo: An update on pathophysiology and treatment options","volume":"18","author":"Speeckaert","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_51","first-page":"CD003263","article-title":"Interventions for vitiligo","volume":"2","author":"Whitton","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5315\/wjh.v3.i4.128","article-title":"Granulysin and its clinical significance as a biomarker of immune response and NK cell related neoplasms","volume":"3","author":"Nagasawa","year":"2014","journal-title":"World J. Hematol."},{"key":"ref_53","first-page":"1136","article-title":"Systemic and local increase of granulysin expression in cytotoxic lymphocytes in severe psoriasis","volume":"99","author":"Massari","year":"2019","journal-title":"Acta Derm.-Venereol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/19\/6894\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T09:48:30Z","timestamp":1759225710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/19\/6894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":53,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["jcm14196894"],"URL":"https:\/\/doi.org\/10.3390\/jcm14196894","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,9,29]]}}}